Using a stent made up of biodegradable polymer, which releases biolimus drug, in patients with ST-segment elevation myocardial infarction who are undergoing angioplasty led to lower number of major adverse cardiac events at the end of one year compared to using bare metal stent, a new study published in JAMA revealed. "The efficacy and safety of drug-eluting [releasing] stents compared with bare-metal stents remains controversial in patients with STEMI undergoing ...Saturday, 25 August 2012
Use of Biodegradable Polymer Stent Reduces Risk of Adverse Cardiac Events in STEMI Patients
Using a stent made up of biodegradable polymer, which releases biolimus drug, in patients with ST-segment elevation myocardial infarction who are undergoing angioplasty led to lower number of major adverse cardiac events at the end of one year compared to using bare metal stent, a new study published in JAMA revealed. "The efficacy and safety of drug-eluting [releasing] stents compared with bare-metal stents remains controversial in patients with STEMI undergoing ...
Labels:
Health News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment